Investigators described the current utilization of antibody–drug conjugates (ADCs) and discussed the prospects of ADC combination therapy for TNBC.
[Cellular and Molecular Life Sciences]
Home Newsletters Mammary Cell News Exploring the Therapeutic Potential of ADC Combination for Triple-Negative Breast Cancer
